Dean Mitchell

Dean Mitchell

Fortune : 8 M $ au 30/06/2026

70 ans
Health Technology
Consumer Services
Commercial Services

Profil

Dean Jonathan Mitchell is currently Independent Chairman at Praxis Precision Medicines, Inc. since 2020 and Lead Independent Director at Theravance Biopharma, Inc. since 2014.
Former roles include President, Chief Executive Officer & Director at Guilford Pharmaceuticals, Inc. (2004-2005), President, Chief Executive Officer & Director at Zoetis Products LLC (2006-2008), President, Chief Executive Officer & Director at Lux Biosciences, Inc. (2010-2013), President & Chief Executive Officer at Alpharma LLC (2006-2008), Chairman at Emergent Travel Health, Inc. (2016-2018), Chairman at National Pharmaceutical Council, Chairman at Covis Pharma Holdings BV (2013-2020), Executive Chairman at Covis Pharma Holdings SARL (2013-2020), Chairman at Paxvax Corp.
(2016-2018), Chairman at Kinnate Biopharma, Inc. (2020-2024), Independent Director at ImmunoGen, Inc. (2012-2024), Non-Executive Director at MGI PHARMA, Inc. (2005-2008), Independent Director at ISTA Pharmaceuticals, Inc. (2004-2012), Director at Talecris Biotherapeutics Holdings Corp., Independent Director at Precigen, Inc. (2009-2024), President-International Pharmaceuticals at Bristol Myers Squibb Co. (2001-2004), Senior VP-Clinical Development & Product Strategy at GSK Plc (1999-2001), and President at MGI GP, Inc. (2005-2006).
Education includes an undergraduate degree from Coventry University and an MBA from Bayes Business School.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
10/06/2026 18 622 ( 0,07 % ) 6 M $ 30/06/2026
12/06/2026 97 213 ( 0,19 % ) 2 M $ 30/06/2026

Postes actifs de Dean Mitchell

SociétésPosteDébut
THERAVANCE BIOPHARMA, INC. Directeur/Membre du Conseil 01/06/2014
PRAXIS PRECISION MEDICINES, INC. Président 17/09/2020

Anciens postes connus de Dean Mitchell

SociétésPosteFin
PRECIGEN, INC. Directeur/Membre du Conseil 05/07/2024
KINNATE BIOPHARMA INC. Président 03/04/2024
IMMUNOGEN, INC. Directeur/Membre du Conseil 12/02/2024
Président 01/03/2020
Président 01/03/2020
Voir l'expérience en détail de Dean Mitchell

Formation de Dean Mitchell

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

72

Relations au 1er degré

22

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées22

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Consumer Services

Commercial Services

MGI GP, Inc.

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Paxvax Corp.

  1. Bourse
  2. Insiders
  3. Dean Mitchell
🔇